Larimar Therapeutics (LRMR) EBIT (2013 - 2026)
Larimar Therapeutics (LRMR) recorded EBIT of -$34.35 million in Q2 2026, compared with -$27.79 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) EBIT (2013 - 2026) Analysis & Trends
On a TTM basis, Larimar Therapeutics' EBIT came in at -$175.66 million as of Jun 30, 2026; for FY2025, it came in at -$172.5 million.
- Across earlier years, EBIT came in at -$90.89 million in FY2024, -$41.76 million in FY2023, -$36.53 million in FY2022 and -$50.47 million in FY2021.
- Quarterly EBIT has ranged from -$64.02 million in Q4 2025 to -$7.64 million in Q1 2023 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Larimar Therapeutics | 252.95 Mn | -354.12 Mn | - | -34.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -34.35 Mn |
| Dec 31, 2025 | -64.02 Mn |
| Sep 30, 2025 | -49.50 Mn |
| Jun 30, 2025 | -27.79 Mn |
| Mar 31, 2025 | -31.19 Mn |
| Dec 31, 2024 | -31.29 Mn |
| Sep 30, 2024 | -18.26 Mn |
| Jun 30, 2024 | -24.60 Mn |
| Mar 31, 2024 | -16.73 Mn |
| Dec 31, 2023 | -14.16 Mn |
| Sep 30, 2023 | -10.34 Mn |
| Jun 30, 2023 | -9.62 Mn |
| Mar 31, 2023 | -7.64 Mn |
| Dec 31, 2022 | -10.44 Mn |
| Sep 30, 2022 | -8.51 Mn |
| Jun 30, 2022 | -8.69 Mn |
| Mar 31, 2022 | -8.89 Mn |
| Dec 31, 2021 | -9.09 Mn |
| Sep 30, 2021 | -16.73 Mn |
| Jun 30, 2021 | -12.54 Mn |
API Access
Larimar Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();